Результаты поиска - Kirk E Evoy

Editorial: Reviews in opioid use disorders по Wendy Walwyn, Kirk E. Evoy, Kirk E. Evoy

Connect to this object online.

Kratom as a potential substance use disorder harm reduction agent по MeShell Green, Nina Vadiei, Nina Vadiei, Charles A. Veltri, Oliver Grundmann, Oliver Grundmann, Kirk E. Evoy, Kirk E. Evoy

Connect to this object online.

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? по Alyssa M Peckham, Kirk E Evoy, Leslie Ochs, Jordan R Covvey

Connect to this object online.

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics по Kirk E Evoy, Chengwen Teng, Victor G Encarnacion, Brian Frescas, John Hakim, Stephen Saklad, Christopher R Frei

Connect to this object online.

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States по Kirk E Evoy, Charles E Leonard, Jordan R Covvey, Leslie Ochs, Alyssa M Peckham, Samantha Soprano, Kelly R Reveles

Connect to this object online.

Quetiapine and olanzapine misuse prevalence in a US general population sample по Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, Shelby Humpert, PharmD, Sorina Torrez, PharmD, Haneen Hussein, PharmD, Jordan R Covvey, PharmD, PhD, BCPS

Connect to this object online.

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids по Payal H. Desai, PharmD, BCCCP, Olesya Taylor, PharmD, BCPS, Kunal J. Shah, PharmD, Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS, Alyssa M. Peckham, PharmD, BCPP

Connect to this object online.